Hillsborough, CA, United States of America

Ruey Sung

This inventor holds 5 USPTO granted patents. Top assignee: Cardima, Inc.. Active years: 1997-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 324(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Ruey Sung

Introduction:

In the realm of medical innovations, inventor Ruey Sung has carved a significant path with his noteworthy contributions. Hailing from Hillsborough, CA, Ruey Sung is a prolific inventor with an impressive portfolio of patents, showcasing his commitment to advancing medical technologies.

Latest Patents:

Ruey Sung’s latest patents include groundbreaking inventions such as the Intravascular RF Occlusion Catheter and Intravascular Method and Device for Occluding a Body Lumen. These inventions focus on utilizing RF electrical energy to coagulate blood within a patient's blood vessel, aiding in the treatment of arrhythmia and other medical conditions.

Career Highlights:

Throughout his career at Cardima, Inc., Ruey Sung has demonstrated a keen ability to innovate and drive progress in the medical device industry. His expertise in developing cutting-edge solutions for cardiac care has solidified his reputation as a pioneer in the field of intravascular medical devices.

Collaborations:

Ruey Sung has collaborated with esteemed professionals in his field, including coworkers Gene L Samson and Duane Dickens. Together, they have worked towards pushing the boundaries of medical technology and enhancing patient care through their innovative contributions.

Conclusion:

In conclusion, Ruey Sung's inventive spirit and dedication to advancing medical technologies have undoubtedly left a lasting impact on the industry. His patents stand as a testament to his innovative prowess and commitment to improving the lives of patients through groundbreaking medical advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…